Ask your provider for a syringe size that makes your dose easy to identify
Focus: GLP-1 receptor agonists, semaglutide, and diabetic eye disease Goal: Help patients and families understand benefits, risks, and when retinal monitoring matters most Evidence-Based: Preferred Practice Patterns Standards of Care Systematic Reviews Meta-Analyses Diabetic Eye Disease Knowledge Hub Start with the complete guide: Diabetic Eye Disease: The Complete Patient Guide Quick Navigation What Are GLP-1 Drugs
The treatment also led to improvements in waist circumference, waist-to-hip ratio, and body image, without affecting blood sugar levels or causing major side effects
Dosage typically begins at 0.25 mg once weekly, with gradual increases to 0.5 mg, 1 mg, or up to 2.4 mg per week, depending on the specific brand and treatment goals
Common examples include certain antidepressants, antipsychotics, corticosteroids, beta-blockers, insulin, and some antiepileptics